URGN · UroGen Pharma Ltd.
$40.88
-0.58 (-1.40%)
At close · Jul 28
Market Cap
$1.99B
Shares
48.72M
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Equity Offering (ATM) Programs
| Program Established | Capacity | Remaining | As of | Runs Through | Source |
|---|---|---|---|---|---|
| 2019-12-01 | $75,000,000 | $42,400,000 | 2025-12-31 | — | 10-K , filed 2026-03-02 |
Key facts
CIK
1668243
CUSIP
M96088105
13F (30d)
24 filings
22 filers
Visit website
Investor relations